These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29497198)

  • 1. Understanding the schizophrenia prodrome.
    George M; Maheshwari S; Chandran S; Manohar JS; Sathyanarayana Rao TS
    Indian J Psychiatry; 2017; 59(4):505-509. PubMed ID: 29497198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do psychosis prodrome onset negative symptoms predict first presentation negative symptoms?
    Lyne J; Renwick L; Madigan K; O'Donoghue B; Bonar M; Grant T; Kinsella A; Malone K; Turner N; O'Callaghan E; Clarke M
    Eur Psychiatry; 2014 Mar; 29(3):153-9. PubMed ID: 23523737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prodromal symptoms of schizophrenia].
    Elkhazen C; Chauchot F; Canceil O; Krebs MO; Baylé FJ
    Encephale; 2003; 29(6):469-77. PubMed ID: 15029081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome.
    Correll CU; Penzner JB; Frederickson AM; Richter JJ; Auther AM; Smith CW; Kane JM; Cornblatt BA
    Schizophr Bull; 2007 May; 33(3):703-14. PubMed ID: 17478437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions.
    Cannon TD; van Erp TG; Bearden CE; Loewy R; Thompson P; Toga AW; Huttunen MO; Keshavan MS; Seidman LJ; Tsuang MT
    Schizophr Bull; 2003; 29(4):653-69. PubMed ID: 14989405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The schizophrenia prodrome revisited: a neurodevelopmental perspective.
    Cornblatt BA; Lencz T; Smith CW; Correll CU; Auther AM; Nakayama E
    Schizophr Bull; 2003; 29(4):633-51. PubMed ID: 14989404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enduring centrality of dopamine in the pathophysiology of schizophrenia: in vivo evidence from the prodrome to the first psychotic episode.
    Bonoldi I; Howes OD
    Adv Pharmacol; 2013; 68():199-220. PubMed ID: 24054146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia: vulnerability versus disease.
    Tsuang MT; Stone WS; Faraone SV
    Dialogues Clin Neurosci; 2000 Sep; 2(3):257-66. PubMed ID: 22034456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The initial prodrome in psychosis: descriptive and qualitative aspects.
    Yung AR; McGorry PD
    Aust N Z J Psychiatry; 1996 Oct; 30(5):587-99. PubMed ID: 8902166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in the schizophrenia prodrome.
    Simon AE; Cattapan-Ludewig K; Zmilacher S; Arbach D; Gruber K; Dvorsky DN; Roth B; Isler E; Zimmer A; Umbricht D
    Schizophr Bull; 2007 May; 33(3):761-71. PubMed ID: 17412711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain morphologic changes in early stages of psychosis: Implications for clinical application and early intervention.
    Takahashi T; Suzuki M
    Psychiatry Clin Neurosci; 2018 Aug; 72(8):556-571. PubMed ID: 29717522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The initial prodrome of schizophrenia: different duration, different underlying deficits?
    Schultze-Lutter F; Ruhrmann S; Hoyer C; Klosterkötter J; Leweke FM
    Compr Psychiatry; 2007; 48(5):479-88. PubMed ID: 17707258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS).
    Singh SP; Cooper JE; Fisher HL; Tarrant CJ; Lloyd T; Banjo J; Corfe S; Jones P
    Schizophr Res; 2005 Dec; 80(1):117-30. PubMed ID: 15978778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intervention and the treatment of prodrome in schizophrenia: a review of recent developments.
    Mokhtari M; Rajarethinam R
    J Psychiatr Pract; 2013 Sep; 19(5):375-85. PubMed ID: 24042243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment implications of the schizophrenia prodrome.
    Kaur T; Cadenhead KS
    Curr Top Behav Neurosci; 2010; 4():97-121. PubMed ID: 21312398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of the psychosis prodrome.
    Powers AR; Addington J; Perkins DO; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH; Woods SW
    Schizophr Res; 2020 Feb; 216():443-449. PubMed ID: 31806523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodrome.
    Olvet DM; Stearns WH; McLaughlin D; Auther AM; Correll CU; Cornblatt BA
    Schizophr Res; 2010 Oct; 123(1):59-63. PubMed ID: 20716479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.
    Correll CU; Smith CW; Auther AM; McLaughlin D; Shah M; Foley C; Olsen R; Lencz T; Kane JM; Cornblatt BA
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):475-90. PubMed ID: 18928412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic N-acetylcysteine treatment improves anhedonia and cognition in a mouse model of the schizophrenia prodrome.
    Bühner LM; Kapanaiah SKT; Kätzel D
    Front Behav Neurosci; 2022; 16():1002223. PubMed ID: 36225391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.
    Yung AR; Phillips LJ; Yuen HP; Francey SM; McFarlane CA; Hallgren M; McGorry PD
    Schizophr Res; 2003 Mar; 60(1):21-32. PubMed ID: 12505135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.